Maternal and neonatal outcomes of dose-dense chemotherapy for breast cancer in pregnancy

Obstetrics and Gynecology

Volumn 120, Issue 6, 2012, Pages 1267-1272

  Cardonick, Elyce ^a   Gilmandyar, Dzhamala ^b   Somer, Robert A ^b  

^a Division of Hematology and Medical Oncology   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIRUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; PACLITAXEL; PROGESTERONE RECEPTOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ARTICLE; BIRTH WEIGHT; BREAST CANCER; CANCER SURVIVAL; DELIVERY; DOSE DENSIFICATION; FEMALE; GESTATIONAL AGE; HUMAN; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; OVERALL SURVIVAL; PREGNANCY OUTCOME; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; ANTINEOPLASTIC AGENTS; BIRTH WEIGHT; BREAST NEOPLASMS; CYCLOPHOSPHAMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; FEMALE; GESTATIONAL AGE; HUMANS; INCIDENCE; MEDICAL STAFF, HOSPITAL; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PREGNANCY OUTCOME; PRENATAL EXPOSURE DELAYED EFFECTS; PREVALENCE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84870163201     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e31826c32d9     Document Type: Article

References (15)

1. Centers for Disease Control and Prevention: Available at: Www.cdc.gov/cancer/dcpc/data/women.htm. Retrieved June 2012.
2. Smith LH, Dalrymple JL, Leiserowitz GS, Danielsen B, Gilbert WM. Obstetrical deliveries associated with maternal malignancy in California, 1992 through 1997. Am J Obstet Gynecol 2001;184:1504-12.
3. Stensheim H, Møller B, van Dijk T, Fosså SD. Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: A registry-based cohort study. J Clin Oncol 2009;27: 45-51.
4. Martin JA, Kochanek KD, Strobino DM, Guyer B, MacDorman MF. Annual summary of vital statistics-2003. Pediatrics 2005;115:619-34.
5. Ranstam J, Janzon L, Olsson H. Rising incidence of breast cancer among young women in Sweden. Br J Cancer 1990; 61:120-2. (Pubitemid 20043556)
6. Ring AE, Smith IE, Ellis PA. Breast cancer and pregnancy. Ann Oncol 2005;16:1855-60. (Pubitemid 41724272)
7. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomized trials. Lancet 2005;365:1687-717.
8. Beadle B, Woodward W, Middleton L, Tereffe W, Strom EA, Litton JK, et al. The impact of pregnancy on breast cancer outcomes in women[lt]or535 years. Cancer 2009;115:1174-84.
9. Cardonick E, Dougherty R, Grana G, Gilmandyar D, Ghaffar S, Usmani A. Breast cancer during pregnancy: Maternal and fetal outcomes. Cancer J 2010;16:76-82.
10. Ring AE, Smith IE, Jones A, Shannon C, Galani E, Ellis PA. Chemotherapy for breast cancer during pregnancy: An 18-year experience from five London teaching hospitals. J Clin Oncol 2005;23:4192-7. (Pubitemid 46211325)
11. Citron ML, Berry DA, Cirrincione C, Hudis C, Winer EP, Gradishar WJ, et al. Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: First report of intergroup trial C9741/Cancer and Leukemia Group B Trial 9741. J Clin Oncol 2003;21:1431-9. (Pubitemid 46594092)
12. Jones RL, Walsh S, Ashley S, Chua S, Agarwal R, O'Brien M, et al. A randomized pilot Phase 2 study of doxorubicin and cyclophosphamide (AC) or epirubicin and cyclophosphamide (EC) given 2 weekly with pegfilgrastim (accelerated) vs 3 weekly (standard) for women with early breast cancer. Br J Cancer 2009;100:305-10.
13. Cardonick E, Irfan F, Torres N. The use of Neupogen (filgrastim) or Neulasta (pegfilgrastim) during pregnancy when chemotherapy is indicated for maternal cancer treatment. J Cancer Ther 2012;3:157-61.
14. Bonilla L, Ben-Aharon I, Vidal L, Gafter-Gvili A, Leibovici L, Stemmer SM. Dose-dense chemotherapy in nonmetastatic breast cancer: A systematic review and meta-analysis of randomized controlled trials. J Natl Cancer Inst 2010;102:1845-54.
15. Cardonick E, Iacobucci A. Use of chemotherapy during human pregnancy. Lancet Oncol 2004;5:283-91. (Pubitemid 38541580)